{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:40:44Z","timestamp":1791294044226,"version":"4.1.0"},"reference-count":105,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.jad.2019.04.039","type":"journal-article","created":{"date-parts":[[2019,4,8]],"date-time":"2019-04-08T20:29:30Z","timestamp":1554755370000},"page":"334-349","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["The effect of adjunctive nutraceuticals in bipolar disorder: A systematic review of randomized placebo-controlled trials"],"prefix":"10.1016","volume":"252","author":[{"given":"Laura","family":"Fusar-Poli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Surace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Vanella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Meo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Patania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosaria","family":"Furnari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Salvina","family":"Signorelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio","family":"Aguglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2019.04.039_bib0001","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2174\/2211556007666180706155506","article-title":"Herbal medication and nutraceuticals for the management of anxiety and depression","volume":"7","author":"Abed","year":"2018","journal-title":"Curr. Psychopharmacol."},{"key":"10.1016\/j.jad.2019.04.039_bib0002","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1111\/j.1399-5618.2007.00466.x","article-title":"Rapid tryptophan depletion as a treatment for acute mania: a double\u2010blind, pilot\u2010controlled study","volume":"9","author":"Applebaum","year":"2007","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2019.04.039_bib0003","series-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-5\u00ae)","year":"2013"},{"key":"10.1016\/j.jad.2019.04.039_bib0004","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1600-0447.1980.tb07683.x","article-title":"The use of rating scales exemplified by a comparison of the Hamilton and the Bech\u2010Rafaelsen Melancholia Scale","volume":"62","author":"Bech","year":"1980","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jad.2019.04.039_bib0005","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1600-0447.2009.01368.x","article-title":"Folic acid efficacy as an alternative drug added to sodium valproate in the treatment of acute phase of mania in bipolar disorder: a double\u2010blind randomized controlled trial","volume":"120","author":"Behzadi","year":"2009","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jad.2019.04.039_bib0006","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1001\/archpsyc.1971.01750150064009","article-title":"The Manic-State Rating Scale: scale construction, reliability, and validity","volume":"25","author":"Beigel","year":"1971","journal-title":"Arch. Gen. Psychiatry."},{"key":"10.1016\/j.jad.2019.04.039_bib0007","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.psychres.2015.04.039","article-title":"Mood disorders are associated with a more severe hypovitaminosis D than schizophrenia","volume":"229","author":"Belzeaux","year":"2015","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2019.04.039_bib0008","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.biopsych.2008.04.022","article-title":"N-acetyl cysteine for depressive symptoms in bipolar disorder\u2014a double-blind randomized placebo-controlled trial","volume":"64","author":"Berk","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2019.04.039_bib0009","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1741-7015-10-91","article-title":"Maintenance N-acetyl cysteine treatment for bipolar disorder: a double-blind randomized placebo controlled trial","volume":"10","author":"Berk","year":"2012","journal-title":"BMC Med."},{"issue":"6","key":"10.1016\/j.jad.2019.04.039_bib0010","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1399-5618.2007.00536.x","article-title":". The Bipolar Depression Rating Scale (BDRS): its development, validation and utility","volume":"9","author":"Berk","year":"2007","journal-title":"Bipolar. Disord."},{"key":"10.1016\/j.jad.2019.04.039_bib0011","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12916-019-1257-1","article-title":"A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo","volume":"17","author":"Berk","year":"2019","journal-title":"BMC Med."},{"key":"10.1016\/j.jad.2019.04.039_bib0012","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/JCP.0000000000000580","article-title":"Prevalence of vitamin D deficiency in adult outpatients with bipolar disorder or schizophrenia","volume":"36","author":"Boerman","year":"2016","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2019.04.039_bib0013","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/JCP.0b013e31829a83f5","article-title":"A placebo-controlled trial of acetyl-l-carnitine and \u03b1-lipoic acid in the treatment of bipolar depression","volume":"33","author":"Brennan","year":"2013","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2019.04.039_bib0014","doi-asserted-by":"crossref","first-page":"e4465","DOI":"10.7717\/peerj.4465","article-title":"An overview on the interplay between nutraceuticals and gut microbiota","volume":"6","author":"Catinean","year":"2018","journal-title":"PeerJ."},{"key":"10.1016\/j.jad.2019.04.039_bib0015","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1001\/archpsyc.1985.01790300064008","article-title":"The assessment of affective disorders in children and adolescents by semistructured interview: test-retest reliability of the schedule for affective disorders and schizophrenia for school-age children, present episode version","volume":"42","author":"Chambers","year":"1985","journal-title":"Arch. Gen.Psychiatry."},{"key":"10.1016\/j.jad.2019.04.039_bib0016","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1034\/j.1399-5618.2000.020107.x","article-title":"Inositol as an add\u2010on treatment for bipolar depression","volume":"2","author":"Chengappa","year":"2000","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2019.04.039_bib0017","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0924-977X(02)00130-X","article-title":"Polyunsaturated fatty acid deficit in patients with bipolar mania","volume":"13","author":"Chiu","year":"2003","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2019.04.039_bib0018","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/0006-3223(85)90026-5","article-title":"A controlled clinical trial of L-tryptophan in acute mania","volume":"20","author":"Chouinard","year":"1985","journal-title":"Biol. Psychiatry."},{"key":"10.1016\/j.jad.2019.04.039_bib0019","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/wps.20204","article-title":"Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder","volume":"14","author":"Correll","year":"2015","journal-title":"World Psychiatry."},{"key":"10.1016\/j.jad.2019.04.039_bib0020","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.2174\/092986709788803060","article-title":"A role for glutathione in the pathophysiology of bipolar disorder and schizophrenia? Animal models and relevance to clinical practice","volume":"16","author":"Dean","year":"2009","journal-title":"Current Med. Chem."},{"key":"10.1016\/j.jad.2019.04.039_bib0021","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1503\/jpn.100057","article-title":"N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action","volume":"36","author":"Dean","year":"2011","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.jad.2019.04.039_bib0022","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1177\/039463200601900402","article-title":"The role of c-reactive protein in mood disorders","volume":"19","author":"De Berardis","year":"2006","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.jad.2019.04.039_bib0023","first-page":"195","article-title":"Evaluation of plasma antioxidant levels during different phases of illness in adult patients with bipolar disorder","volume":"22","author":"De Berardis","year":"2008","journal-title":"J Biol. Regul. Homeost. Agents."},{"key":"10.1016\/j.jad.2019.04.039_bib0024","first-page":"133","article-title":"The role of cholesterol levels in mood disorders and suicide","volume":"23","author":"De Berardis","year":"2009","journal-title":"J. Biol. Regul. Homeost. Agents."},{"key":"10.1016\/j.jad.2019.04.039_bib0025","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0924-2244(00)88944-X","article-title":"The nutraceutical revolution: its impact on food industry R&D","volume":"6","author":"DeFelice","year":"1995","journal-title":"Trends Food Sci. Technol."},{"key":"10.1016\/j.jad.2019.04.039_bib0026","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/bdi.12652","article-title":"Adjunctive probiotic microorganisms to prevent rehospitalization in patients with acute mania: a randomized controlled trial","volume":"20","author":"Dickerson","year":"2018","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2019.04.039_bib0027","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.bbi.2016.12.010","article-title":"The microbiome, immunity, and schizophrenia and bipolar disorder","volume":"62","author":"Dickerson","year":"2017","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jad.2019.04.039_bib0028","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jad.2014.06.023","article-title":". Bipolar disorder and gambling disorder comorbidity: current evidence and implications for pharmacological treatment","volume":"167","author":"Di Nicola","year":"2014","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2019.04.039_bib0029","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1399-5618.2006.00303.x","article-title":"Inositol augmentation of lithium or valproate for bipolar depression","volume":"8","author":"Evins","year":"2006","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2019.04.039_bib0030","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40345-018-0117-9","article-title":"Add-on treatment with N-acetylcysteine for bipolar depression: a 24-week randomized double-blind parallel group placebo-controlled multicentre trial (NACOS-study protocol)","volume":"6","author":"Ellegaard","year":"2018","journal-title":"Int. J. Bipolar Disord."},{"key":"10.1016\/j.jad.2019.04.039_bib0031","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.jad.2018.10.083","article-title":". The efficacy of adjunctive N-acetylcysteine in acute bipolar depression: a randomized placebo-controlled study","volume":"245","author":"Ellegaard","year":"2019","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2019.04.039_bib0032","first-page":"321","article-title":"Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure","volume":"29","author":"Endicott","year":"1993","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.jad.2019.04.039_bib0033","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1001\/archpsyc.1976.01770060086012","article-title":"The Global Assessment Scale: a procedure for measuring overall severity of psychiatric disturbance","volume":"33","author":"Endicott","year":"1976","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2019.04.039_bib0034","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jpsychires.2016.12.007","article-title":". The gut microbiome composition associates with bipolar disorder and illness severity","volume":"87","author":"Evans","year":"2017","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2019.04.039_bib0035","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1192\/bjp.188.1.46","article-title":"Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: randomised double-blind placebo-controlled study","volume":"188","author":"Frangou","year":"2006","journal-title":"Br. J. Psychiatry."},{"key":"10.1016\/j.jad.2019.04.039_bib0036","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1089\/cap.2015.0132","article-title":"A randomized controlled trial of individual family psychoeducational psychotherapy and omega-3 fatty acids in youth with subsyndromal bipolar disorder","volume":"25","author":"Fristad","year":"2015","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.jad.2019.04.039_bib0037","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/JCP.0000000000000523","article-title":"Adherence to antipsychotic medication in bipolar disorder and schizophrenic patients: a systematic review","volume":"36","author":"Garc\u00eda","year":"2016","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2019.04.039_bib0038","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0165-1781(99)00116-X","article-title":"Magnesium oxide augmentation of verapamil maintenance therapy in mania","volume":"93","author":"Giannini","year":"2000","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2019.04.039_bib0039","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s00213-001-0970-5","article-title":"A dose-finding study on the effects of branch chain amino acids on surrogate markers of brain dopamine function","volume":"160","author":"Gijsman","year":"2002","journal-title":"Psychopharmacology."},{"key":"10.1016\/j.jad.2019.04.039_bib0040","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s40345-016-0068-y","article-title":"Lithium side effects and toxicity: prevalence and management strategies","volume":"4","author":"Gitlin","year":"2016","journal-title":"Int. J. Bipolar Disord."},{"key":"10.1016\/j.jad.2019.04.039_bib0041","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1177\/0269881116636545","article-title":"Evidence-based guidelines for treating bipolar disorder: revised third edition recommendations from the British Association for Psychopharmacology","volume":"30","author":"Goodwin","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jad.2019.04.039_bib0042","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1399-5618.2010.00799.x","article-title":"Randomized, placebo\u2010controlled trial of flax oil in pediatric bipolar disorder","volume":"12","author":"Gracious","year":"2010","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2019.04.039_bib0043","doi-asserted-by":"crossref","first-page":"e96905","DOI":"10.1371\/journal.pone.0096905","article-title":"Role of omega-3 fatty acids in the treatment of depressive disorders: a comprehensive meta-analysis of randomized clinical trials","volume":"9","author":"Grosso","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.jad.2019.04.039_bib0044","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3109\/15622975.2013.770551","article-title":"The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder","volume":"14","author":"Grunze","year":"2013","journal-title":"World J. Biol. Psychiatry."},{"key":"10.1016\/j.jad.2019.04.039_bib0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002058","article-title":"Adverse renal, endocrine, hepatic, and metabolic events during maintenance mood stabilizer treatment for bipolar disorder: a population-based cohort study","volume":"13","author":"Hayes","year":"2016","journal-title":"PLoS Medicine"},{"key":"10.1016\/j.jad.2019.04.039_bib0046","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ."},{"key":"10.1016\/j.jad.2019.04.039_bib0047","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.brainres.2005.01.007","article-title":"Central administration of IGF-I and BDNF leads to long-lasting antidepressant-like effects","volume":"1037","author":"Hoshaw","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.jad.2019.04.039_bib0048","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ebiom.2017.02.020","article-title":"Nutritional psychiatry: where to next?","volume":"17","author":"Jacka","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jad.2019.04.039_bib0049","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1192\/bjp.bp.116.187989","article-title":"Pharmacological treatment and risk of psychiatric hospital admission in bipolar disorder","volume":"210","author":"Joas","year":"2017","journal-title":"Br. J. Psychiatry."},{"key":"10.1016\/j.jad.2019.04.039_bib0050","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1192\/bjp.166.5.654","article-title":"A brief mental health outcome scale: reliability and validity of the Global Assessment of Functioning (GAF)","volume":"166","author":"Jones","year":"1995","journal-title":"Br. J. Psychiatry."},{"key":"10.1016\/j.jad.2019.04.039_bib0051","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.biopsych.2006.03.056","article-title":"Double-blind, randomized, placebo-controlled trials of ethyl-eicosapentanoate in the treatment of bipolar depression and rapid cycling bipolar disorder","volume":"60","author":"Keck","year":"2006","journal-title":"Biol. Psychiatry."},{"key":"10.1016\/j.jad.2019.04.039_bib0052","doi-asserted-by":"crossref","first-page":"g5673","DOI":"10.1136\/bmj.g5673","article-title":"Assessment and management of bipolar disorder: summary of updated NICE guidance","volume":"349","author":"Kendall","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.jad.2019.04.039_bib0053","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1017\/S0033291799008570","article-title":"The range of impaired functioning tool (LIFE\u2013RIFT): a brief measure of functional impairment","volume":"29","author":"Leon","year":"1999","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jad.2019.04.039_bib0054","series-title":"Inpatient Multidimensional Psychiatric Scale (IMPS)","author":"Lorr","year":"1962"},{"key":"10.1016\/j.jad.2019.04.039_bib0055","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11011-008-9118-1","article-title":"The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression","volume":"24","author":"Maes","year":"2009","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.jad.2019.04.039_bib0056","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1590\/S1516-44462011000400011","article-title":"N-acetylcysteine for major depressive episodes in bipolar disorder","volume":"33","author":"Magalh\u00e3es","year":"2011","journal-title":"Braz. J. Psychiatry."},{"key":"10.1016\/j.jad.2019.04.039_bib0057","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0165-0327(88)90072-9","article-title":"The Hamilton Anxiety Scale: reliability, validity and sensitivity to change in anxiety and depressive disorders","volume":"141","author":"Maier","year":"1988","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2019.04.039_bib0058","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3748\/wjg.v22.i1.361","article-title":"Gut microbiota in autism and mood disorders","volume":"22","author":"Mangiola","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.jad.2019.04.039_bib0059","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jpsychires.2017.07.021","article-title":"Vitamin D supplementation in bipolar depression: a double blind placebo controlled trial","volume":"95","author":"Marsh","year":"2017","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2019.04.039_bib0060","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.pnpbp.2011.01.013","article-title":"Acetyl-l-Carnitine in the treatment of anhedonia, melancholic and negative symptoms in alcohol dependent subjects","volume":"35","author":"Martinotti","year":"2011","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry."},{"key":"10.1016\/j.jad.2019.04.039_bib0061","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0166-2236(03)00032-8","article-title":"Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders","volume":"26","author":"Mattson","year":"2003","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.jad.2019.04.039_bib0062","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/archgenpsychiatry.2011.12","article-title":"Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative","volume":"68","author":"Merikangas","year":"2011","journal-title":"Arch. Gen. Psychiatry."},{"key":"10.1016\/j.jad.2019.04.039_bib0063","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/JCP.0000000000000938","article-title":"Evaluating the effect of coenzyme Q10 Augmentation on treatment of bipolar depression: a double-blind controlled clinical trial","volume":"38","author":"Mehrpooya","year":"2018","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2019.04.039_bib0064","first-page":"1","article-title":"Psychobiotics: a new approach for treating mental illness?","author":"Misra","year":"2017","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.jad.2019.04.039_bib0065","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann. Intern. Med."},{"issue":"4","key":"10.1016\/j.jad.2019.04.039_bib0066","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to chang","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br. J. Psychiatry."},{"key":"10.1016\/j.jad.2019.04.039_bib0067","article-title":"Omega\u20103 fatty acids for bipolar disorder","volume":"2","author":"Montgomery","year":"2008","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jad.2019.04.039_bib0068","first-page":"323","article-title":"Development, reliability and acceptability of a new version of the DSM\u2010IV Social and Occupational Functioning Assessment Scale (SOFAS) to assess routine social funtioning","volume":"101","author":"Morosini","year":"2000","journal-title":"Acta Psych. Scand."},{"key":"10.1016\/j.jad.2019.04.039_bib0069","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/JCP.0b013e318266854c","article-title":"Omega-3 fatty acid treatment, with or without cytidine, fails to show therapeutic properties in bipolar disorder: a double-blind, randomized add-on clinical trial","volume":"32","author":"Murphy","year":"2012","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2019.04.039_bib0070","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1017\/S0033291700052065","article-title":"Vanadium: a possible aetiological factor in manic depressive illness","volume":"11","author":"Naylor","year":"1981","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jad.2019.04.039_bib0071","series-title":"Advances in Magnesium Research\u2013New Data","first-page":"25","article-title":"Variation of magnesium concentration in psychosis","author":"Nechifor","year":"2006"},{"key":"10.1016\/j.jad.2019.04.039_bib0072","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.jamda.2016.12.071","article-title":"Clinical use of curcumin in depression: a meta-analysis","volume":"18","author":"Ng","year":"2017","journal-title":"J Am Med Dir Assoc."},{"key":"10.1016\/j.jad.2019.04.039_bib0073","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The brief psychiatric rating scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychol. Rep."},{"key":"10.1016\/j.jad.2019.04.039_bib0074","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.pnpbp.2008.04.016","article-title":"Effect of the methylenetetrahydrofolate reductase gene polymorphisms on homocysteine, folate and vitamin B12 in patients with bipolar disorder and relatives","volume":"32","author":"Ozbek","year":"2008","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry."},{"key":"10.1016\/j.jad.2019.04.039_bib0075","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/109786","article-title":"Targeting the glutamatergic system to treat pathological gambling: current evidence and future perspectives","volume":"2014","author":"Pettorruso","year":"2014","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.jad.2019.04.039_bib0076","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2174\/1570163811310030007","article-title":"Randomized placebo-controlled trials of omega-3 polyunsaturated fatty acids in psychiatric disorders: a review of the current literature","volume":"10","author":"Politi","year":"2013","journal-title":"Curr. Drug Discov. Technol."},{"key":"10.1016\/j.jad.2019.04.039_bib0077","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jpsychires.2012.11.004","article-title":"Plasma levels of n-3 fatty acids in bipolar patients: deficit restricted to DHA","volume":"47","author":"Pomponi","year":"2013","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2019.04.039_bib0078","series-title":"Children's Depression Rating Scale, Revised (CDRS-R)","author":"Poznanski","year":"1996"},{"key":"10.1016\/j.jad.2019.04.039_bib0079","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1001\/jamainternmed.2015.8581","article-title":"Changes in prescription and over-the-counter medication and dietary supplement use among older adults in the United States, 2005vs 2011","volume":"176","author":"Qato","year":"2016","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.jad.2019.04.039_bib0080","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1146\/annurev-pharmtox-010617-052844","article-title":"Adverse effects of nutraceuticals and dietary supplements","volume":"58","author":"Ronis","year":"2018","journal-title":"Annu. Rev. Pharmacol Toxicol."},{"key":"10.1016\/j.jad.2019.04.039_bib0081","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1745-0179-3-5","article-title":"Validity and reliability of the Functioning Assessment Short Test (FAST) in bipolar disorder","volume":"3","author":"Rosa","year":"2007","journal-title":"Clin. Pract. Epidemiol. Ment. Health"},{"key":"10.1016\/j.jad.2019.04.039_bib0082","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1177\/2045125318769235","article-title":"Epidemiology and risk factors for bipolar disorder","volume":"8","author":"Rowland","year":"2018","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"10.1016\/j.jad.2019.04.039_bib0083","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1017\/S0033291700035558","article-title":"The inventory of depressive symptomatology (IDS): psychometric properties","volume":"26","author":"Rush","year":"1996","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jad.2019.04.039_bib0084","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ejps.2016.09.003","article-title":"Nutraceuticals: a paradigm of proactive medicine","volume":"96","author":"Santini","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jad.2019.04.039_bib0085","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/bcp.13496","article-title":"Nutraceuticals: opening the debate for a regulatory framework","volume":"84","author":"Santini","year":"2018","journal-title":"Brit. J. Clin. Pharmaco."},{"key":"10.1016\/j.jad.2019.04.039_bib0086","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1177\/1039856216689533","article-title":"Clinical use of nutraceuticals in the adjunctive treatment of depression in mood disorders","volume":"25","author":"Sarris","year":"2017","journal-title":"Australas. Psychiatry"},{"key":"10.1016\/j.jad.2019.04.039_bib0087","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/j.1399-5618.2011.00945.x","article-title":"Adjunctive nutraceuticals with standard pharmacotherapies in bipolar disorder: a systematic review of clinical trials","volume":"13","author":"Sarris","year":"2011","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2019.04.039_bib0088","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1176\/appi.ajp.2016.15091228","article-title":"Adjunctive nutraceuticals for depression: a systematic review and meta-analyses","volume":"173","author":"Sarris","year":"2016","journal-title":"Am. J. Psychiatry."},{"key":"10.1016\/j.jad.2019.04.039_bib0089","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1192\/bjp.182.3.210","article-title":"Effects of a branched-chain amino acid drink in mania","volume":"182","author":"Scarna","year":"2003","journal-title":"Br. J. Psychiatry."},{"key":"10.1016\/j.jad.2019.04.039_bib0090","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/wps.20174","article-title":"Novel psychoactive substances of interest for psychiatry","volume":"14","author":"Schifano","year":"2015","journal-title":"World Psychiatry."},{"key":"10.1016\/j.jad.2019.04.039_bib0091","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jad.2017.11.020","article-title":"Saffron in the treatment of depression, anxiety and other mental disorders: current evidence and potential mechanisms of action","volume":"227","author":"Shafiee","year":"2018","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2019.04.039_bib0092","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4103\/2008-7802.182734","article-title":"Effects of omega-3 supplement in the treatment of patients with bipolar I disorder","volume":"7","author":"Shakeri","year":"2016","journal-title":"Int. J. Prev. Med."},{"key":"10.1016\/j.jad.2019.04.039_bib0093","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1034\/j.1399-5618.2000.020201.x","article-title":"Serotonin in mania and in the mechanism of action of mood stabilizers: a review of clinical studies","volume":"2","author":"Shiah","year":"2000","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2019.04.039_bib0094","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jad.2015.10.026","article-title":"Decreased serum zinc concentration during depressive episode in patients with bipolar disorder","volume":"190","author":"Siwek","year":"2016","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2019.04.039_bib0095","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0165-1781(97)00123-6","article-title":"Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP","volume":"73","author":"Spearing","year":"1997","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2019.04.039_bib0096","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1172\/JCI116245","article-title":"Dietary omega-3 polyunsaturated fatty acids inhibit phosphoinositide formation and chemotaxis in neutrophils","volume":"91","author":"Sperling","year":"1993","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jad.2019.04.039_bib0097","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1001\/archpsyc.56.5.407","article-title":"Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial","volume":"56","author":"Stoll","year":"1999","journal-title":"Arch. Gen. Psychiatry."},{"key":"10.1016\/j.jad.2019.04.039_bib0098","doi-asserted-by":"crossref","first-page":"129","DOI":"10.9758\/cpn.2015.13.2.129","article-title":"Omega-3 Polyunsaturated Fatty Acids in Prevention of Mood and Anxiety Disorders","volume":"13","author":"Su","year":"2015","journal-title":"Clin. Psychopharmacol. Neurosci."},{"key":"10.1016\/j.jad.2019.04.039_bib0099","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00702-017-1817-5","article-title":"A randomized, double-blind, placebo-controlled, proof-of-concept trial of creatine monohydrate as adjunctive treatment for bipolar depression","volume":"125","author":"Toniolo","year":"2018","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.jad.2019.04.039_bib0100","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1001\/archpsyc.1988.01800320058007","article-title":"A structured interview guide for the Hamilton Depression Rating Scale","volume":"45","author":"Williams","year":"1988","journal-title":"Arch. Gen. Psychiatry."},{"key":"10.1016\/j.jad.2019.04.039_bib0101","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1089\/neu.2004.21.1457","article-title":"Dietary omega-3 fatty acids normalize BDNF levels, reduce oxidative damage, and counteract learning disability after traumatic brain injury in rats","volume":"21","author":"Wu","year":"2004","journal-title":"J. Neurotrauma."},{"key":"10.1016\/j.jad.2019.04.039_bib0102","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.2527\/jas.2013-6755","article-title":"Regulation of N-acetyl cysteine on gut redox status and major microbiota in weaned piglets","volume":"92","author":"Xu","year":"2014","journal-title":"J. Anim. Sci."},{"key":"10.1016\/j.jad.2019.04.039_bib0103","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"Br. J. Psychiatry."},{"key":"10.1016\/j.jad.2019.04.039_bib0104","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1007\/BF00441950","article-title":"Biochemical aspects of tryptophan depletion in primates","volume":"98","author":"Young","year":"1989","journal-title":"Psychopharmacology."},{"key":"10.1016\/j.jad.2019.04.039_bib0105","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/1753-0407.12795","article-title":"N-Acetylcysteine alleviates gut dysbiosis and glucose metabolic disorder in high-fat diet-fed mice","volume":"11","author":"Zheng","year":"2019","journal-title":"J. Diabetes."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032719302988?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032719302988?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T01:29:02Z","timestamp":1759022942000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032719302988"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":105,"alternative-id":["S0165032719302988"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2019.04.039","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of adjunctive nutraceuticals in bipolar disorder: A systematic review of randomized placebo-controlled trials","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2019.04.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}